New 1,3-oxazolo[4,5-c]quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties

European Journal of Medicinal Chemistry

Volumn 45, Issue 3, 2010, Pages 957-966

  Eswaran, Sumesh ^a   Adhikari, Airody Vasudeva ^b   Ajay Kumar, R ^c  

^a Anthem Biosciences Pvt Ltd   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY KARNATAKA   (India)

^c RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

1,3 oxazolo 4,5 c quinoline; Antibacterial activity; Antituberculosis activity; X ray crystallography

Indexed keywords

1 [2 (3 FLUOROPHENYL) 4 HYDROXYQUINOLIN 3 YL] 3 (2 METHOXYPHENYL)UREA; 1 [2 (4 FLUOROPHENYL) 4 HYDROXYQUINOLIN 3 YL] 3 (2 METHOXYPHENYL)UREA; 1,3 OXAZOLO[4,5 C]QUINOLINE; 4 (3 FLUOROPHENYL) N (2 METHOXYPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; 4 (3 FLUOROPHENYL) N (4 FLUOROPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; 4 (4 FLUOROPHENYL) N (2 METHOXYPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; ISONIAZID; N BENZYL 4 (3 FLUOROPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; N BENZYL 4 (4 FLUOROPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; N,4 BIS (4 FLUOROPHENYL)[1,3]OXAZOLO[4,5 C]QUINOLIN 2 AMINE; QUINOLINE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; OXAZOLES; PSEUDOMONAS AERUGINOSA; QUINOLINES; STAPHYLOCOCCUS AUREUS;

EID: 76049098678     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.11.036     Document Type: Article

References (39)

1. WHO Global Tuberculosis Control Report, 2008.
2. Jain R., Vaitilingam B., Nayyar A., and Palde P.B. Bioorg. Med. Chem. Lett. 13 (2003) 1051-1054
3. WHO Weekly epidemiological record No. 15. 78 (2003)121-128.
4. Zignol M., Hosseini M.S., Wright A., Weezenbeek C.L., Nunn P., Watt C.J., Williams C.G., and Dye C. J. Infect. Dis. 194 (2006) 479-485
5. Lilienkampf A., Mao J., Wan B., Wang Y., Franzblau S.G., and Kozikowski A.P. J. Med. Chem. 52 (2009) 2109-2118
6. Nasveld P., and Kitchener S. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 2-5
7. Leatham P.A., Bird H.A., Wright V., Seymour D., and Gordon A. Eur. J. Rheumatol. Inflamm. 6 (1983) 209-211
8. W.A. Denny, W.R. Wilson, D.C. Ware, G.J. Atwell, J.B. Milbank, R.J. Stevenson, U.S Patent 7064117 (2006).
9. Mahamoud A., Chevalier J., Davin-Regli A., Barbe J., and Pages J.-M. Curr. Drug Targ. 7 (2006) 843-847
10. Muruganantham N., Sivakumar R., Anbalagan N., Gunasekaran V., and Leonard J.T. Biol. Pharm. Bull. 27 (2004) 1683-1687
11. Maguire M.P., Sheets K.R., McVety K., Spada A.P., and Zilberstein A. J. Med. Chem. 37 (1994) 2129-2137
12. Wilson W.D., Zhao M., Patterson S.E., Wydra R.L., Janda L., and Strekowski L. Med. Chem. Res. 2 (1992) 102-110
13. Strekowski L., Mokrosz J.L., Honkan V.A., Czarny A., Cegla M.T., Patterson S.E., Wydra R.L., and Schinazi R.F. J. Med. Chem. 34 (1991) 1739-1746
14. Aggarwal A.K., and Jenekhe S.A. Macromolecules 24 (1991) 6806-6808
15. Zhang X., Shetty A.S., and Jenekhe S.A. Macromolecules 32 (1999) 7422-7429
16. Jenekhe S.A., Lu L., and Alam M.M. Macromolecules 34 (2001) 7315-7324
17. Jason M.E., Robert W.C., Mark C., Gary G.C., Peter H.H., Brian A.J., MacLeod A., Rose M., Georgina M.L., Elena M., Fraser M., Michael R., Inmaculada R., Michael G.N.R., Bindi S., Kwei L.T., and Brian W. Bioorg. Med. Chem. Lett. 50 (2006) 5748-5751
18. Nilsson J., Nielsen E.Ø., Liljefors T., Nielsen M., and Sterner O. Bioorg. Med. Chem. Lett. 18 (2008) 5713-5716
19. Simeon M., John N., Georgia L., Eleni K., Vasiliki G., Dimitrios T., and Pavlos N. Int. J. of Antimicrob. Agents 29 (2007) 738-748
20. Kaila N., Janz K., DeBernardo S., Bedard P.W., Camphausen R.T., Tam S., Tsao D.H.H., Keith Jr. J.C., Nutter C.N., Shilling A., Sciame R.Y., and Wang Q. J. Med. Chem. 50 (2007) 21-39
21. Andersen K.E., Lundt B.F., Jørgensen A.S., and Braestrup C. Eur J Med Chem. 31 (1996) 417-425
22. Sasaki H., Haraguchi Y., Itotani M., Kuroda H., Hashizume H., Tomishige T., Kawasaki M., Matsumoto M., Komatsu M., and Tsubouchi H. J. Med. Chem. 49 (2006) 7854-7860
23. Mohamed K., Venugopala N.K., Mohana R., and Krishna R.G. Lett. Drug Des. Discov. 6 (2009) 21-28
24. Kuang R., Shue H.-J., Blythin D.J., Shih N.-Y., Gu D., Chen X., Schwerdt J., Lin L., Ting P.C., Zhu X., Aslanian R., Piwinski J.J., Xiao L., Prelusky D., Wu P., Zhang J., Zhang X., Celly C.S., Minnicozzi M., and Billah M. Bioorg. Med. Chem. Lett. 17 (2007) 5150-5154
25. C. Jeong-woo, L. Sang-chul, M. Cheol-young, H. Sun-gwan, B. Sung-jin, K. Eun-ae, WO Patent 075888 A1 (2006).
26. D.A. Evrard, D. Zhou, G.P. Stack, A.M. Venkatesan, A.A. Failli, S.C. Croce, US Patent 7153849 B2 (2006).
27. Drabczyńska A., Müller C.E., Schumacher B., Hinz S., Wojciechowska J.K., Michalak B., Pe{ogonek}kala E., and Kononowicz K.K. Bioorg. Med. Chem. 12 (2004) 4895-4908
28. Eswaran S., Adhikari A.V., and Shetty N.S. Eur. J. Med. Chem. 44 (2009) 4637-4647
29. Colotta V., Capelli F., Lenzi O., Catarzi D., Varano F., Poli D., Vincenzi F., Varani K., Borea P.A., Ben D.D., Volpini R., Cristalli G., and Filacchioni G. Bioorg. Med. Chem. 17 (2009) 401-410
30. Gerster J.F., Lindstrom K.J., Miller R.L., Tomai M.A., Birmachu W., Bomersine S.N., Gibson S.J., Imbertson L.M., Jacobson J.R., Knafla R.T., Maye P.V., Nikolaides N., Oneyemi F.Y., Parkhurst G.J., Pecore S.E., Reiter M.J., Scribner L.S., Testerman T.L., Thompson N.J., Wagner T.L., Weeks C.E., Andre J.D., Lagain D., Bastard Y., and Lupu M. J. Med. Chem. 48 (2005) 3481-3491
31. Dinakaran M., Senthilkumar P., Yogeeswari P., China A., Nagaraja V., and Sriram D. Bioorg. Med. Chem. 16 (2008) 3408-3418
32. Marco A., Loza-Mejía, Olvera-Vázquez S., Maldonado-Hernández K., Salgado T.G., González-Sánchez I., Rodríguez-Hernández F., Solano J.D., Rodríguez-Sotres R., and Rocha A.L. Bioorg. Med. Chem. 17 (2009) 3266-3277
33. Izumi T., Sakaguchi J., Takeshita M., Tawara H., Kato K.-i., Dose H., Tsujino T., Watanabe Y., and Kato H. Bioorg. Med. Chem. 11 (2003) 2541-2550
34. Barry A.L. Procedure for testing antimicrobial agents in agar media. In: Corian V.L. (Ed). Antibiotics in Laboratory Medicine (1980), Williams and Wilkins, Baltimore, MD 1-23
35. James D., Lowry Mac., Jaqua J.M., and Sally T.S. Appl. Microbiol. 20 (1970) 46-53
36. Martin A., Camacho M., Portaels F., and Palomino J.C. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob. Agents Chemother. 47 (2003) 3616-3619
37. Coban A.Y., Cekic C.C., Bilgin K., Uzun M., Akgunes A., Cetinkaya E., and Durupinar B. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes. J Chemother. 18 (2006) 140-143
38. Fenlon C.H., and Cynamon M.H. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob. Agents Chemother 29 (1986) 386-388
39. Davis R., Markham A., and Balfour J.A. Ciprofloxacin, An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 51 (1996) 1019-1074